SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 44,021 Value ($000) $239 Avg Close Range
Q3 2024
Shares 42,721 Value ($000) $308 Avg Close Range
Q2 2024
Shares 29,521 Value ($000) $321 Avg Close Range
Q1 2024
Shares 29,521 Value ($000) $553 Avg Close Range
Q4 2023
Shares 31,010 Value ($000) $672 Avg Close Range
Q3 2023
Shares 31,010 Value ($000) $638 Avg Close Range
Q2 2023
Shares 31,010 Value ($000) $1,458 Avg Close Range
Q1 2023
Shares 31,010 Value ($000) $1,301 Avg Close Range
Q4 2022
Shares 31,010 Value ($000) $1,183 Avg Close Range
Q3 2022
Shares 15,060 Value ($000) $590 Avg Close Range
Q2 2022
Shares 7,940 Value ($000) $256 Avg Close Range
Q1 2022
Shares 7,940 Value ($000) $263 Avg Close Range
Q4 2021
Shares 7,940 Value ($000) $338 Avg Close Range
Q3 2021
Shares 21,567 Value ($000) $956 Avg Close Range
Q2 2021
Shares 29,312 Value ($000) $1,665 Avg Close Range
Q1 2021
Shares 20,560 Value ($000) $1,539 Avg Close Range
Q4 2020
Shares 26,050 Value ($000) $2,253 Avg Close Range
Q3 2020
Shares 26,050 Value ($000) $1,592 Avg Close Range
Q2 2020
Shares 12,984 Value ($000) $539 Avg Close Range
Q1 2020
Shares 15,099 Value ($000) $433 Avg Close Range
Q4 2019
Shares 19,356 Value ($000) $1,397 Avg Close Range